Signifying the importance of its corporate wellness initiatives, Spafinder Wellness, Inc.® has named Claudia Rimerman the senior vice president, corporate group and wellness.

Signifying the importance of its corporate wellness initiatives, Spafinder Wellness, Inc.® has named Claudia Rimerman the senior vice president, corporate group and wellness. In the newly created position, Rimerman, who previously held management roles at AIG, UnitedHealth Group®, Humana Inc. and Corporate Health Systems, will lead the company’s Corporate Wellness 365™ division and develop incentive […]

Performance Health, manufacturer and marketer of Biofreeze®, Bon Vital’® and TheraBand™ branded products, recently announced…

Performance Health, manufacturer and marketer of Biofreeze®, Bon Vital’® and TheraBand™ branded products, recently announced the promotion of Lynda Solien-Wolfe to vice president of massage and spa. Solien-Wolfe began working with Performance Health as a consultant in 1999 and became a full-time employee in 2009. Over the past 15 years, she has been uniquely responsible […]

Sante Spa Victoria is the second spa to achieve SpaExcellence…

Sante Spa Victoria, a resort spa located in the Westin Bear Mountain Golf Resort and Spa in Victoria, British Columbia, Canada, is the second spa to achieve SpaExcellence under the updated International Standards of SpaExcellenceSM 2014 from SpaQuality LLC. The Standards provide a framework for everything that a spa does including strategic planning, day-to-day operations, behind-the-scenes […]

The Professional Beauty Association (PBA) recently announced…

The Professional Beauty Association (PBA) recently announced the recipients of the 2014 PBA Sally Beauty Scholarship. With over 300 applicants, the selection process was challenging based on the quality of candidates. Applications for the 2015 PBA Sally Beauty Scholarships are now available in the two categories below. The deadline for entry is November 14th, 2014.

FDA recently announced that it had granted a first-ever approval of a combination treatment for melanoma

The United States Food and Drug Administration (FDA) recently announced that it had granted a first-ever approval of a combination treatment for melanoma, the most deadly type of skin cancer. The agency approved the combination of GlaxoSmithKline’s genetically-targeted dabrafenib (Tafinlar™) and trametinib (Mekinist™) for patients with metastatic or unresectable melanoma whose tumors possess either the […]

Register